[1]
Karigane D, Takaya S, Seki Y, Mastumoto Y, Onose A, Kosakai A, Sugaya N, Mori T. Cytomegalovirus enteritis in immunocompetent subjects: a case report and review of the literature. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2014 May:20(5):325-9. doi: 10.1016/j.jiac.2013.12.004. Epub 2014 Jan 24
[PubMed PMID: 24751234]
Level 3 (low-level) evidence
[2]
Ko JH, Peck KR, Lee WJ, Lee JY, Cho SY, Ha YE, Kang CI, Chung DR, Kim YH, Lee NY, Kim KM, Song JH. Clinical presentation and risk factors for cytomegalovirus colitis in immunocompetent adult patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015 Mar 15:60(6):e20-6. doi: 10.1093/cid/ciu969. Epub 2014 Dec 1
[PubMed PMID: 25452594]
[3]
Lee HS, Park SH, Kim SH, Kim J, Choi J, Lee HJ, Kim WS, Lee JM, Kwak MS, Hwang SW, Yang DH, Kim KJ, Ye BD, Byeon JS, Myung SJ, Yoon YS, Yu CS, Kim JH, Yang SK. Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis. Inflammatory bowel diseases. 2016 Apr:22(4):912-8. doi: 10.1097/MIB.0000000000000675. Epub
[PubMed PMID: 26829410]
Level 2 (mid-level) evidence
[4]
Banerjee D, Deb R, Dar L, Mirdha BR, Pati SK, Thareja S, Falodia S, Ahuja V. High frequency of parasitic and viral stool pathogens in patients with active ulcerative colitis: report from a tropical country. Scandinavian journal of gastroenterology. 2009:44(3):325-31. doi: 10.1080/00365520802556809. Epub
[PubMed PMID: 19040190]
[5]
Wada Y, Matsui T, Matake H, Sakurai T, Yamamoto J, Kikuchi Y, Yorioka M, Tsuda S, Yao T, Yao S, Haraoka S, Iwashita A. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Diseases of the colon and rectum. 2003 Oct:46(10 Suppl):S59-65
[PubMed PMID: 14530660]
[6]
Criscuoli V, Casà A, Orlando A, Pecoraro G, Oliva L, Traina M, Rizzo A, Cottone M. Severe acute colitis associated with CMV: a prevalence study. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2004 Dec:36(12):818-20
[PubMed PMID: 15646428]
[7]
Domènech E, Vega R, Ojanguren I, Hernández A, Garcia-Planella E, Bernal I, Rosinach M, Boix J, Cabré E, Gassull MA. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflammatory bowel diseases. 2008 Oct:14(10):1373-9. doi: 10.1002/ibd.20498. Epub
[PubMed PMID: 18452205]
Level 2 (mid-level) evidence
[8]
Maconi G, Lombardini M, Furfaro F, Bezzio C, Zerbi P, Ardizzone S. Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis: effect of antiviral treatment. European journal of gastroenterology & hepatology. 2014 Oct:26(10):1146-51. doi: 10.1097/MEG.0000000000000175. Epub
[PubMed PMID: 25089547]
[9]
Park SC, Jeen YM, Jeen YT. Approach to cytomegalovirus infections in patients with ulcerative colitis. The Korean journal of internal medicine. 2017 May:32(3):383-392. doi: 10.3904/kjim.2017.087. Epub 2017 Apr 20
[PubMed PMID: 28490715]
[10]
Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. The American journal of gastroenterology. 2001 Jul:96(7):2137-42
[PubMed PMID: 11467645]
[11]
Shukla T, Singh S, Tandon P, McCurdy JD. Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Journal of clinical gastroenterology. 2017 May/Jun:51(5):394-401. doi: 10.1097/MCG.0000000000000758. Epub
[PubMed PMID: 27875356]
Level 1 (high-level) evidence
[12]
McCurdy JD, Jones A, Enders FT, Killian JM, Loftus EV Jr, Smyrk TC, Bruining DH. A model for identifying cytomegalovirus in patients with inflammatory bowel disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2015 Jan:13(1):131-7; quiz e7. doi: 10.1016/j.cgh.2014.05.026. Epub 2014 Jun 30
[PubMed PMID: 24993369]
[13]
Bhutani D, Dyson G, Manasa R, Deol A, Ratanatharathorn V, Ayash L, Abidi M, Lum LG, Al-Kadhimi Z, Uberti JP. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Jan:21(1):159-64. doi: 10.1016/j.bbmt.2014.10.004. Epub 2014 Oct 16
[PubMed PMID: 25445637]
[14]
Yang H, Zhou W, Lv H, Wu D, Feng Y, Shu H, Jin M, Hu L, Wang Q, Wu D, Chen J, Qian J. The Association Between CMV Viremia or Endoscopic Features and Histopathological Characteristics of CMV Colitis in Patients with Underlying Ulcerative Colitis. Inflammatory bowel diseases. 2017 May:23(5):814-821. doi: 10.1097/MIB.0000000000001095. Epub
[PubMed PMID: 28426459]
Level 2 (mid-level) evidence
[15]
Chidlovskii E, Deroux A, Bernard S, Couturier P. Cytomegalovirus colitis mimicking rectal carcinoma in an immunocompetent elderly woman. BMJ case reports. 2016 May 10:2016():. doi: 10.1136/bcr-2016-214694. Epub 2016 May 10
[PubMed PMID: 27166009]
Level 3 (low-level) evidence
[16]
Levin A, Yaari S, Stoff R, Caplan O, Wolf DG, Israeli E. Diagnosis of Cytomegalovirus Infection during Exacerbation of Ulcerative Colitis. Digestion. 2017:96(3):142-148. doi: 10.1159/000479865. Epub 2017 Aug 26
[PubMed PMID: 28848127]
[17]
Suzuki H, Kato J, Kuriyama M, Hiraoka S, Kuwaki K, Yamamoto K. Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World journal of gastroenterology. 2010 Mar 14:16(10):1245-51
[PubMed PMID: 20222169]
[18]
Matsuda K, Ono S, Ishikawa M, Miyamoto S, Abiko S, Tsuda M, Yamamoto K, Kudo T, Shimizu Y, Hayase E, Hashimoto D, Teshima T, Matsuno Y, Sakamoto N. Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Annals of hematology. 2018 May:97(5):877-883. doi: 10.1007/s00277-018-3241-9. Epub 2018 Jan 16
[PubMed PMID: 29340759]
[19]
Juric-Sekhar G, Upton MP, Swanson PE, Westerhoff M. Cytomegalovirus (CMV) in gastrointestinal mucosal biopsies: should a pathologist perform CMV immunohistochemistry if the clinician requests it? Human pathology. 2017 Feb:60():11-15. doi: 10.1016/j.humpath.2016.09.009. Epub 2016 Sep 22
[PubMed PMID: 27666768]
[20]
Landry ML, Ferguson D. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. Journal of clinical microbiology. 1993 Nov:31(11):2851-6
[PubMed PMID: 8263166]
[21]
Yerushalmy-Feler A, Padlipsky J, Cohen S. Diagnosis and Management of CMV Colitis. Current infectious disease reports. 2019 Feb 15:21(2):5. doi: 10.1007/s11908-019-0664-y. Epub 2019 Feb 15
[PubMed PMID: 30771028]
[22]
Beswick L, Ye B, van Langenberg DR. Toward an Algorithm for the Diagnosis and Management of CMV in Patients with Colitis. Inflammatory bowel diseases. 2016 Dec:22(12):2966-2976
[PubMed PMID: 27763950]
[23]
Goodrich JM, Mori M, Gleaves CA, Du Mond C, Cays M, Ebeling DF, Buhles WC, DeArmond B, Meyers JD. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. The New England journal of medicine. 1991 Dec 5:325(23):1601-7
[PubMed PMID: 1658652]
[24]
Barling DR, Tucker S, Varia H, Isaacs P. Large bowel perforation secondary to CMV colitis: an unusual primary presentation of HIV infection. BMJ case reports. 2016 Dec 21:2016():. doi: 10.1136/bcr-2016-217221. Epub 2016 Dec 21
[PubMed PMID: 28003231]
Level 3 (low-level) evidence
[25]
Hasegawa T, Aomatsu K, Nakamura M, Aomatsu N, Aomatsu K. Cytomegalovirus colitis followed by ischemic colitis in a non-immunocompromised adult: a case report. World journal of gastroenterology. 2015 Mar 28:21(12):3750-4. doi: 10.3748/wjg.v21.i12.3750. Epub
[PubMed PMID: 25834346]
Level 3 (low-level) evidence
[26]
Kotton CN. CMV: Prevention, Diagnosis and Therapy. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2013 Feb:13 Suppl 3():24-40; quiz 40. doi: 10.1111/ajt.12006. Epub
[PubMed PMID: 23347212]
[27]
Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, Humar A, The Transplantation Society International CMV Consensus Group. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation. 2018 Jun:102(6):900-931. doi: 10.1097/TP.0000000000002191. Epub
[PubMed PMID: 29596116]
Level 3 (low-level) evidence